Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Altimmune Inc (NQ: ALT )

13.27 USD +0.34 (+2.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Altimmune Inc

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Add Up The Parts: JKJ Could Be Worth $0
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Thinking about buying stock in Nokia, BioCryst Pharmaceuticals, Beam Therapeutics, Altimmune, or Citius Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for NOK, BCRX, BEAM, ALT, and CTXR. 
From PR Newswire
Altimmune to Present at Upcoming Scientific Conferences
From GlobeNewswire News Releases
Altimmune Clears Technical Benchmark, Hitting 80-Plus RS Rating
Altimmune sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
First Week of December 17th Options Trading For Altimmune (ALT)
Investors in Altimmune Inc (ALT) saw new options begin trading this week, for the December 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the... 
Tags Stocks
From Market News Video
Altimmune Trying To Close In On Key Technical Benchmark
A Relative Strength Rating upgrade for Altimmune shows improving technical performance. Will it continue? 
From Investor's Business Daily
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?
The short answer: It depends. 
Tags Market News ALT AZN
From Motley Fool
Alternus Energy Group (ALT) Completes 9 Million (91 Million NOK) Funding, Led by Nordic ESG and Impact Investor, AV Group Sarl
From NewMediaWire
DWAS's Underlying Holdings Imply 14% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Altimmune's Anthrax Vaccine Candidate Shows Early Safety, Immunogenicity In Healthy Volunteers
Altimmune Inc(NASDAQ:ALT) hasreported datafrom Phase 1b trial evaluating its NasoShield intranasal anthrax ... 
Tags Biotech Phase 1 Trial Anthrax
From Benzinga
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™
From GlobeNewswire News Releases
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate
Metered Multidose Device Allows for Convenient and Cost-effective Vaccination 
From GlobeNewswire News Releases
Is Altimmune a Buy?
If you're thinking of investing in this spectacular coronavirus growth stock, now may be too late. 
Tags ALT IBB Market News
From Motley Fool
Thinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean?
InvestorsObserver issues critical PriceWatch Alerts for INVO, NCLH, NOVN, ALT, and RIG. 
From PR Newswire
Altimmune's Shares Are Trading Higher On Intranasal COVID-19 Vaccine Candidate's Promising Action In Animal Studies
Altimmune Inc(NASDAQ:ALT) hasreported additional preclinical datafor COVID-19 vaccine candidate, ... 
Tags COVID/19 Vaccine General Biotech
From Benzinga
AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection
From GlobeNewswire News Releases
Why ContraFect, Evoke, Altimmune, Novavax Are Moving Friday
Among the health care stock moversFriday are ContraFect Corporation (NASDAQ: CFRX), Evoke Pharma, Inc. (NASDAQ: EVOK), Altimmune, ... 
Tags Movers Biotech CFRX
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Small Cap MGTA Benzinga
From Benzinga
38 Stocks Moving in Friday's Pre-Market Session
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares rose 51.7% to $6.13 in pre-market trading. Entera Bio shares climbed over 152% on ... 
Tags ITRM RYB CYCC
From Benzinga
Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza
Altimmune Inc(NASDAQ:ALT)has expandeditspreviously-announcedmanufacturing collaboration ... 
Tags COVID/19 Vaccine General Biotech
From Benzinga
76 Biggest Movers From Yesterday
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares climbed 152.5% to close at $4.04 on Thursday after the company disclosed positive ... 
Tags Benzinga IMAC YALA
From Benzinga
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston Facility 
From GlobeNewswire News Releases
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 284% to $6.15 after the company disclosed positive topline EB613 Phase 2 ... 
Tags QTT TIGR SLGG
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Savara (NASDAQ:SVRA) stock increased by 16.75% to $2.09 during Wednesday's after-market session. Trading volume for this ... 
Tags BZI/TFM After/Hours Center AVEO
From Benzinga
Thinking about buying stock in Altimmune, Invo Bioscience, Norwegian Cruise Line, ADC Therapeutics, or Clovis Oncology?
InvestorsObserver issues critical PriceWatch Alerts for ALT, INVO, NCLH, ADCT, and CLVS. 
From PR Newswire
Altimmune Joins Rank Of Stocks With RS Ratings Over 90
Altimmune sees its Relative Strength Rating reach the elite 90-plus level. 
From Investor's Business Daily
Altimmune to Present at Upcoming Conferences
From GlobeNewswire News Releases
IBB's Holdings Could Mean 28% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
ALTIMMUNE INC (ALT) Q4 2020 Earnings Call Transcript
ALT earnings call for the period ending December 31, 2020. 
Tags ALT Market News
From Motley Fool
Positive news on COVID vaccines weighs against concerns over new variants
The COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE has proved to be as effective in the real world as it was in clinical trials in the first major study of the two-dose... 
Tags SPX DJIA GILD
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.